Atlas Trials

Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver Resection

Clinical trial NCT02555293 · TERMINATED

Trial details

NCT number
NCT02555293
Sponsor
RWTH Aachen University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Liver DiseaseMajor Liver Resection
Start date
2016-02-01
Primary completion
2020-11-20
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.